penclomedine

Penclomedine is a synthetic derivative of pyrimidine with antineoplastic activity. It acts primarily by alkylating and crosslinking DNA, leading to DNA strand breaks and inhibition of both DNA and RNA synthesis. This mechanism makes it more active against tumor cells that are defective in p53 function. Penclomedine has been investigated in clinical trials for the treatment of lymphoma and unspecified adult solid tumors. Its development included evaluation as an oral agent to improve toxicity profiles compared to intravenous administration, with particular interest in its central nervous system penetration for potential use in intracranial neoplasms[1][2][3][4].

Other names

penclomedine3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl)pyridine